Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

Europe - BIT:SVS - IT0005469264 - Common Stock

8.1 EUR
-0.04 (-0.49%)
Last: 8/18/2025, 7:00:00 PM
Fundamental Rating

6

Overall SVS gets a fundamental rating of 6 out of 10. We evaluated SVS against 59 industry peers in the Health Care Equipment & Supplies industry. SVS has only an average score on both its financial health and profitability. SVS may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SVS had positive earnings in the past year.
In the past year SVS had a positive cash flow from operations.
SVS had positive earnings in each of the past 5 years.
Each year in the past 5 years SVS had a positive operating cash flow.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

SVS has a Return On Assets of 3.44%. This is comparable to the rest of the industry: SVS outperforms 54.24% of its industry peers.
SVS has a Return On Equity of 9.25%. This is in the better half of the industry: SVS outperforms 69.49% of its industry peers.
With a decent Return On Invested Capital value of 7.57%, SVS is doing good in the industry, outperforming 69.49% of the companies in the same industry.
SVS had an Average Return On Invested Capital over the past 3 years of 6.10%. This is below the industry average of 8.90%.
The 3 year average ROIC (6.10%) for SVS is below the current ROIC(7.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SVS has a Profit Margin (4.49%) which is in line with its industry peers.
SVS's Profit Margin has improved in the last couple of years.
SVS has a Operating Margin (8.07%) which is in line with its industry peers.
SVS's Operating Margin has improved in the last couple of years.
SVS has a Gross Margin of 25.79%. This is amonst the worse of the industry: SVS underperforms 83.05% of its industry peers.
SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SVS is creating some value.
SVS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SVS has been reduced compared to 5 years ago.
Compared to 1 year ago, SVS has a worse debt to assets ratio.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.86 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SVS's Altman-Z score of 1.86 is in line compared to the rest of the industry. SVS outperforms 44.07% of its industry peers.
The Debt to FCF ratio of SVS is 1707.47, which is on the high side as it means it would take SVS, 1707.47 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1707.47, SVS is in line with its industry, outperforming 40.68% of the companies in the same industry.
SVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating SVS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, SVS is not doing good in the industry: 66.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Altman-Z 1.86
ROIC/WACC1.08
WACC7.03%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.96, SVS is doing good in the industry, outperforming 61.02% of the companies in the same industry.
SVS has a Quick Ratio of 1.42. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.42, SVS is doing good in the industry, outperforming 71.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.52%, which is quite impressive.
Measured over the past years, SVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.81% on average per year.
The Revenue has grown by 12.19% in the past year. This is quite good.
The Revenue has been growing by 11.34% on average over the past years. This is quite good.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

SVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.27% yearly.
Based on estimates for the next years, SVS will show a small growth in Revenue. The Revenue will grow by 7.40% on average per year.
EPS Next Y20.69%
EPS Next 2Y26.85%
EPS Next 3Y18.84%
EPS Next 5Y16.27%
Revenue Next Year5.8%
Revenue Next 2Y10.67%
Revenue Next 3Y8.58%
Revenue Next 5Y7.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

SVS is valuated cheaply with a Price/Earnings ratio of 7.94.
Based on the Price/Earnings ratio, SVS is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of SVS to the average of the S&P500 Index (27.20), we can say SVS is valued rather cheaply.
A Price/Forward Earnings ratio of 5.73 indicates a rather cheap valuation of SVS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 98.31% of the companies listed in the same industry.
SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 7.94
Fwd PE 5.73
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SVS is cheaper than 94.92% of the companies in the same industry.
SVS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1219.35
EV/EBITDA 3.6
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SVS may justify a higher PE ratio.
SVS's earnings are expected to grow with 18.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.38
PEG (5Y)0.35
EPS Next 2Y26.85%
EPS Next 3Y18.84%

4

5. Dividend

5.1 Amount

SVS has a Yearly Dividend Yield of 3.06%. Purely for dividend investing, there may be better candidates out there.
SVS's Dividend Yield is rather good when compared to the industry average which is at 2.30. SVS pays more dividend than 89.83% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, SVS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.06%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y26.85%
EPS Next 3Y18.84%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

SVAS BIOSANA SPA

BIT:SVS (8/18/2025, 7:00:00 PM)

8.1

-0.04 (-0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap45.36M
Analysts80
Price Target13.87 (71.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.94
Fwd PE 5.73
P/S 0.37
P/FCF 1219.35
P/OCF 7.41
P/B 0.77
P/tB 0.96
EV/EBITDA 3.6
EPS(TTM)1.02
EY12.59%
EPS(NY)1.41
Fwd EY17.46%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.5%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC7.03%
ROIC/WACC1.08
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y26.85%
EPS Next 3Y18.84%
EPS Next 5Y16.27%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.67%
Revenue Next 3Y8.58%
Revenue Next 5Y7.4%
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%